Sort   by:  
 Page size 
UnknownDeciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression.
Not available
S-EPMC11755887 | biostudies-literature
UnknownFerroptosis, necroptosis, and pyroptosis in anticancer immunity.
Not available
S-EPMC7418434 | biostudies-literature
UnknownApplications of single-cell sequencing in cancer research: progress and perspectives.
Not available
S-EPMC8190846 | biostudies-literature
UnknownTargeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Not available
S-EPMC9733270 | biostudies-literature
UnknownRole of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
Not available
S-EPMC8028808 | biostudies-literature
UnknownTPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality.
Not available
S-EPMC11874363 | biostudies-literature
UnknownCRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
Not available
S-EPMC10715495 | biostudies-literature
UnknownIntegrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: Hypoxia in PDAC.
Not available
S-EPMC10206494 | biostudies-literature
UnknownTargeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response.
Not available
S-EPMC10591062 | biostudies-literature
Sort   by:  
 Page size